Cruzeiro do Sul Educacional (CSED3) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
28 Aug, 2026Executive summary
Achieved record adjusted net earnings of R$187 million in 2024, up 72.5% year-over-year, and proposed or paid record dividends of R$137 million, representing a 95% payout of net earnings.
Net revenue grew 11.8% to R$2.6 billion, driven by a 12.2% increase in the student base to 526,000, with strong growth in both on-campus and digital segments.
Free cash flow reached R$328 million, a 323% increase over 2023, with free cash flow to equity at R$266 million, representing 65% of EBITDA ex-IFRS 16.
Financial leverage improved, with net debt/EBITDA ex-IFRS 16 at 1.4x, down from 1.6x in 2023, despite significant M&A activity and dividend payments.
Financial highlights
Adjusted EBITDA rose 12% to R$766.3 million in 2024, with a stable margin of 29.8%.
Gross profit increased 13.8% to R$1.25 billion, with gross margin expanding by 0.9 percentage points to 48.7%.
Adjusted net earnings margin improved by 2.6 percentage points to 7.3% in 2024.
Capex reduced by 30.4% to R$141.3 million, reflecting a shift toward technology investments.
Days of receivables reduced to 31 days, down 14 days year-over-year.
Outlook and guidance
CapEx for 2025 expected to remain in line with 2024, with no major increases anticipated barring significant acquisitions.
Management remains confident in sustainable growth, supported by business unit structure, technology investments, and digital transformation initiatives.
Initiatives to improve collections and reduce delinquency are expected to keep PDA at or below 6% of net revenue in 2025.
Sufficient cash to cover all 2025 debt maturities and nearly half of 2026 maturities.
Latest events from Cruzeiro do Sul Educacional
- Revenue and net income surged, driven by student growth, digital gains, and FAPI acquisition.CSED3
Q2 2024 - Record free cash flow and net earnings in 3Q24, with strong growth in students and margins.CSED3
Q3 2024 - Record earnings, margin expansion, and robust cash flow driven by student and health segment growth.CSED3
Q1 2025 - Net revenue and earnings surged, student base grew 13.9%, and leverage improved to 1.1x.CSED3
Q2 2025 - Net income up 82% in 3Q25, with strong digital and health growth and lower leverage.CSED3
Q3 2025 - Record net profit, margin expansion, and robust cash flow highlight strong 2025 performance.CSED3
Q4 2025 - Revenue up 4.5% year-over-year, but net profit down 28.1% amid higher costs and provisions.CSED3
Q1 2026 - Net income rose 61% and adjusted EBITDA margin reached 29.9% on strong healthcare and hybrid growth.CSED3
Q2 2026